Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
Recent: |
|
Past: |
|
Bridger Aerospace looks attractive, with a reasonable valuation and a growing end market. While it may see a run or two, see why I rate BAER stock a Sell. → Read More
Like so many de-SPAC mergers, Inspirato has disappointed since going public, but trades at reasonable multiples to revenue and gross profit. Read more here. → Read More
Amid a second leg of the market sell-off, BLBD is threatening to hit an all-time low. With normalcy likely on the horizon, BLBD has big potential upside. → Read More
DWAC has been a roller-coaster, with volatility driven by the drama at Twitter as well as market-wide valuation concerns. See the outlook for DWAC here. → Read More
Somehow, Lytus Technologies became 2022's hottest IPO - though it has quickly crashed back to Earth. Read what investors need to know about LYT here. → Read More
ARKK has been emblematic of the dizzying rise in speculative growth stocks — and their equally spectacular fall. What's the outlook now? Find out here. → Read More
A seemingly exciting story has done little for Mullen stock, which is off 90%-plus from its highs and 75% so far this year. See the outlook for MULN here. → Read More
Over the last two decades, comparisons to the 'dot-com bubble' have badly underestimated the mania of the late 1990s. → Read More
Berkshire Hathaway's stake in Barrick is a notable U-turn given chairman Warren Buffett's long-held skepticism toward the yellow metal. → Read More
A 27% YTD decline in LW's stock looks potentially overdone, given reasonably defensive fast-food demand and a still-intact international growth story. → Read More
Fundamentally, CRON stock looks like a sell, even as it flirts with multi-year lows. But the company's strategy is responsible for some of the revenue weakness relative to cannabis peers. → Read More
T's 7% dividend yield seems attractive - but it also highlights the risk to the stock. Beyond the dividend, the problems with AT&T are obvious. → Read More
PetMed Express' Q1 report last week looked strong on its face — but the resulting sell-off makes some sense. → Read More
FirstEnergy stock plunged 34% in two days amid a bribery scandal in Ohio. The bill in question benefited nuclear power plants owned by a former subsidiary — but that doesn't mean FirstEnergy is immune to the fallout. → Read More
Optimism toward Moderna's coronavirus vaccine drove MRNA stock higher last week — but appears to have boosted other names as well, at least momentarily. → Read More
Lakeland Industries is a potential beneficiary of the coronavirus pandemic — but there's more to the story as well. → Read More
SOLO stock has soared along with other EV names. The rally seems like too much, given a lack of revenue and a questionable use case for the Solo. → Read More
AGS stock was one of the big winners off March lows, but second wave concerns have led it to fade 40%-plus from June highs. → Read More
Rite Aid clearly is heading in the right direction, as front-end sales have improved and market share has expanded. But industry conditions, most notably reimbu → Read More
Owens & Minor looked at significant risk of bankruptcy just a year ago, but new management has begun to right the ship. Renewed coronavirus concerns have led to → Read More